Intelligent Bio Solutions, Inc. (INBS)
1.52
-0.01
(-0.65%)
USD |
NASDAQ |
Oct 12, 15:55
Intelligent Bio Solutions Profit Margin (Quarterly) : -341.9% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -341.9% |
| March 31, 2026 | -270.5% |
| December 31, 2025 | -299.6% |
| September 30, 2025 | -269.4% |
| June 30, 2025 | -367.7% |
| March 31, 2025 | -349.9% |
| December 31, 2024 | -371.5% |
| September 30, 2024 | -308.9% |
| Date | Value |
|---|---|
| June 30, 2024 | -384.1% |
| March 31, 2024 | -362.6% |
| December 31, 2023 | -258.7% |
| September 30, 2023 | -305.5% |
| June 30, 2023 | -602.9% |
| March 31, 2023 | -1.39K% |
| December 31, 2022 | -119.7% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Sanara MedTech, Inc. | -1.46% |
| Anteris Technologies Global Corp. | -2.85K% |
| 20/20 Biolabs, Inc. | -206.2% |
| Quest Diagnostics, Inc. | 10.94% |
| Labcorp Holdings, Inc. | 8.02% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -200.0% |
| Return on Assets | -98.80% |
| Return on Invested Capital | -159.9% |
| Gross Profit Margin (Quarterly) | 21.68% |
| Operating Margin (Quarterly) | -367.5% |
| Return on Net Operating Assets | -190.6% |